Výsledky léčby a sledování pacientů se spinocelulárními karcinomy hlavy a krku po konkomitantní léčbě cetuximabem a radioterapií
| Title in English | Outcomes of treatment and follow-up of patients with squamous cell head and neck cancers after concomitant |
|---|---|
| Authors | |
| Year of publication | 2013 |
| Type | Article in Periodical |
| Magazine / Source | Onkologie |
| MU Faculty or unit | |
| Citation | |
| Field | Oncology and hematology |
| Keywords | head and neck cancers; cetuximab; EGFR; ADCC |
| Attached files | |
| Description | The paper presents outcomes of treatment with cetuximab and radiotherapy in patients with squamous cell head and neck cancers as well as of post-treatment follow-up. Treatment outcomes were very good in our patients; among 30 patients, a total of 90% of complete remissions in locoregionally advanced stages were observed. In the subsequent follow-up, the 2-year overall survival was achieved in 82% and the 2-year symptom-free survival in 76% of patients. |